Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases?

Bibliographic Details
Main Authors: Claudio Viegas, Carlos A. Manssour Fraga, Maria Emilia Sousa, Andrea Tarozzi
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.609274/full
id doaj-94ca53e8c7d44aeb90f569b3cd2745d3
record_format Article
spelling doaj-94ca53e8c7d44aeb90f569b3cd2745d32020-12-09T06:45:56ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-12-011110.3389/fphar.2020.609274609274Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases?Claudio Viegas0Carlos A. Manssour Fraga1Maria Emilia Sousa2Andrea Tarozzi3Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, BrazilFaculty of Pharmacy, University of Porto, Porto, PortugalDepartment for Life Quality Studies, University of Bologna, Bologna, ItalyLaboratory of Research in Medicinal Chemistry (PeQuiM), Federal University of Alfenas, Alfenas, Brazilhttps://www.frontiersin.org/articles/10.3389/fphar.2020.609274/fulloxidative stressneurodegenerative diseasesAlzheirmer's diseaseParkinsion’s diseaseHuntington (disease)amyotrofic lateral sclerosis
collection DOAJ
language English
format Article
sources DOAJ
author Claudio Viegas
Carlos A. Manssour Fraga
Maria Emilia Sousa
Andrea Tarozzi
spellingShingle Claudio Viegas
Carlos A. Manssour Fraga
Maria Emilia Sousa
Andrea Tarozzi
Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases?
Frontiers in Pharmacology
oxidative stress
neurodegenerative diseases
Alzheirmer's disease
Parkinsion’s disease
Huntington (disease)
amyotrofic lateral sclerosis
author_facet Claudio Viegas
Carlos A. Manssour Fraga
Maria Emilia Sousa
Andrea Tarozzi
author_sort Claudio Viegas
title Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases?
title_short Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases?
title_full Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases?
title_fullStr Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases?
title_full_unstemmed Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases?
title_sort editorial: oxidative stress: how has it been considered in the design of new drug candidates for neurodegenerative diseases?
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2020-12-01
topic oxidative stress
neurodegenerative diseases
Alzheirmer's disease
Parkinsion’s disease
Huntington (disease)
amyotrofic lateral sclerosis
url https://www.frontiersin.org/articles/10.3389/fphar.2020.609274/full
work_keys_str_mv AT claudioviegas editorialoxidativestresshowhasitbeenconsideredinthedesignofnewdrugcandidatesforneurodegenerativediseases
AT carlosamanssourfraga editorialoxidativestresshowhasitbeenconsideredinthedesignofnewdrugcandidatesforneurodegenerativediseases
AT mariaemiliasousa editorialoxidativestresshowhasitbeenconsideredinthedesignofnewdrugcandidatesforneurodegenerativediseases
AT andreatarozzi editorialoxidativestresshowhasitbeenconsideredinthedesignofnewdrugcandidatesforneurodegenerativediseases
_version_ 1724388318241619968